Corona Virus Vaccine | When will we get Corona Virus Vaccine? | Oxford University Corona Vaccine

COVID-19 Vaccine 

ChAdOx1    nCoV-19

Britain has succeeded in making the Corona virus vaccine. Phase 3 clinical trial of covid-19 vaccine developed by University of Oxford will be completed by the end of November of early December, an official said. University of Oxford joinef hand with British Swedish firm Astrazeneca to make a COVID-19 vaccine. 

The phase 3 trail has already started in  United States and Brazil. The vaccine has shown promosing result in the first phase of clinical human trail. The researchers said that tey fimd their experiment COVID-19 produced a dual immune response in people aged 18 to 55. "We are seeing good immune response in almost everyday", said Dr Adrian Hill, director of the Jenner Institute at Oxford University. 

During the human trials, the university found that this vaccine developed immunity to fight the corona virus in people. It would not be wrong to call it a major achievement in the work of vaccine manufacture across the world against the covid-19 epidemic.

Chalking out a plan to combat the COVID-19 Novel Coronavirus with SAARC leaders.
- Narendra Modi

The human trial of the Corona vaccine prepared by Oxford University in Britain has yielded positive results. Researchers at Oxford are excited by these results, but it is believed that it will have to wait until it is clear whether the vaccine can sustain immunity against the corona virus for a long time.

Follow us on Instagram to know more such Fun Facts

It is being told that the production of this vaccine, will start bulk production by September. Explain that there is a tie-up between Oxford University and pharmaceutical company AstraZeneca. AstraZeneca is developing the vaccine in collaboration with Oxford University. Let us tell you that Moderna is trying to make 100 million doses with Catalent Inc by the first quarter of 2020.